APA (7th ed.) Citation

Rudebeck, C. J., Renard, C., Halfon‐Domenech, C., Ouachée‐Chardin, M., Philippe, M., Valla, F. V., . . . Penel‐Page, M. (2022). Interest of the preventive and curative use of defibrotide on the occurrence and severity of sinusoidal obstruction syndrome after hematopoietic stem cell transplant in children. eJHaem, 3(3), 885. https://doi.org/10.1002/jha2.480

Chicago Style (17th ed.) Citation

Rudebeck, Carl J., Cécile Renard, Carine Halfon‐Domenech, Marie Ouachée‐Chardin, Michael Philippe, Frederic V. Valla, Yves Bertrand, and Mathilde Penel‐Page. "Interest of the Preventive and Curative Use of Defibrotide on the Occurrence and Severity of Sinusoidal Obstruction Syndrome After Hematopoietic Stem Cell Transplant in Children." EJHaem 3, no. 3 (2022): 885. https://doi.org/10.1002/jha2.480.

MLA (9th ed.) Citation

Rudebeck, Carl J., et al. "Interest of the Preventive and Curative Use of Defibrotide on the Occurrence and Severity of Sinusoidal Obstruction Syndrome After Hematopoietic Stem Cell Transplant in Children." EJHaem, vol. 3, no. 3, 2022, p. 885, https://doi.org/10.1002/jha2.480.